Start with the clinical purpose of a test

An advertised laboratory panel is not automatically the right evaluation for a person's symptoms. Ask the clinician what question each proposed test is intended to answer and how its result could change the plan. Fatigue, sleep concerns or changes in body composition should not be treated as a diagnosis just because they appear in a sermorelin advertisement.

The Endocrine Society's adult growth-hormone deficiency guideline says confirmation usually requires stimulation testing, with specified exceptions. A consumer wellness panel or an isolated laboratory value should therefore not be presented as a universal substitute for a proper diagnostic evaluation.

Available testing and included testing are different terms

Maximus describes before-and-after IGF-1 testing available through its laboratory service. Defy describes comprehensive assessment and laboratory work when needed. Neither phrase, by itself, establishes the price of all tests a particular patient will receive. Ask for an itemized quotation before assuming the medication price covers the clinical evaluation.

Also ask whether a blood draw, laboratory processing and clinician interpretation are billed together or separately. The provider may arrange a test while another organization performs and bills it. Understanding that sequence prevents an unexpected invoice from being mistaken for a duplicate charge.

Bring existing records, but let the clinician judge relevance

If you already have recent results, ask whether they can be reviewed before paying for a new panel. Supply the report with its date, units and reference ranges rather than a single number copied into a message. The clinician may still need different or more recent testing; avoiding a duplicate purchase should not override medical judgment.

Ask about local collection options and whether the ordered test can be completed where you live. A remote consultation does not mean every laboratory step is remote, and travel, scheduling or collection fees can become part of the practical cost.

Put reassessment on the calendar and the budget

Request the anticipated first follow-up date, the type of appointment and the planned testing, if any. Ask who reviews results and whether a prescription renewal waits for that review. A clear sequence is more useful than a vague promise of ongoing monitoring.

Discuss the goal being evaluated as well as any laboratory marker. The clinician should explain how they will decide whether to continue, adjust or stop. More tests are not automatically better care, and a changed biomarker alone does not establish that a patient's desired outcome has improved.

Get answers for exceptions before they occur

Ask what an additional consultation costs if unwanted effects, an unexpected result or a new medical condition require review before the scheduled visit. Clarify whether provider messaging is included and whether that channel can arrange an appointment when needed. Do not assume a customer-service agent can interpret medical results.

Your final cost sheet should identify the initial assessment, expected follow-up and possible separately billed services. Mark uncertain charges openly. This creates a usable budget without turning the guide into a testing protocol or encouraging readers to order laboratory work without the responsible clinician's direction.

Sources & further reading

Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.

  1. Endocrine Society: Evaluation and Treatment of Adult Growth Hormone Deficiency Clinical
  2. Maximus: Growth Hormone Peptides Provider
  3. Defy Medical: Peptide Therapy Provider